The Board of FarmPharma has now, with the support of the authorization received at the extraordinary general meeting on November 19, 2018, implemented a directed new issue of a total of 2 145 470 SEK. The issue is directed at private and institutional investors and is expected to be registered within 3 weeks. Issue costs consist only of registration costs for the issue. Double Bond Pharmaceuticals ownership part is thereby reduced from 92% till 76%.

“We see a great need in the community for FarmPharma products, both from sustainability and environmental perspectives. – says on Igor Lokot, CEO of Double Bond Pharmaceutical and Chairman of the board for FarmPharma, – The ongoing new share issue raises cash to maintain the high pace of development of the company ”

Source: Spotlight

By |2019-01-19T09:30:56+00:00January 19th, 2019|